Palatin Technologies, Inc. (PTN)
5.52
-0.47
(-7.85%)
USD |
NASDAQ |
Oct 20, 16:00
5.60
+0.08
(+1.45%)
After-Hours: 20:00
Palatin Technologies Profit Margin (Quarterly) : -1.45K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.45K% |
| March 31, 2026 | -36.55% |
| December 31, 2025 | -6.26K% |
| September 30, 2025 | 52.87% |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | -2.36K% |
| March 31, 2024 | |
| December 31, 2023 | -385.6% |
| September 30, 2023 | -247.2% |
| June 30, 2023 | -557.3% |
| March 31, 2023 | -725.0% |
| December 31, 2022 | |
| September 30, 2022 | -949.2% |
| June 30, 2022 | -1.66K% |
| March 31, 2022 | -3.53K% |
| December 31, 2021 | -2.70K% |
| September 30, 2021 | -4.46K% |
| June 30, 2021 | -7.95K% |
| March 31, 2021 | -6.46K% |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | -25.45K% |
| September 30, 2019 | -4.62K% |
| June 30, 2019 | 86.66% |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -16.47K% |
| June 30, 2018 | 57.27% |
| March 31, 2018 | -8.25% |
| December 31, 2017 | 28.55% |
| September 30, 2017 | 39.36% |
| June 30, 2017 | 39.28% |
| March 31, 2017 | -32.93% |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 34.63% |
| September 30, 2014 | 16.11% |
| June 30, 2014 | |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
| Vericel Corp. | 2.85% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -171.9% |
| Return on Assets | -81.25% |
| Return on Invested Capital | -164.1% |
| Gross Profit Margin (Quarterly) | 94.35% |
| Operating Margin (Quarterly) | -1.47K% |
| Return on Net Operating Assets | -340.9% |